Induction of apoptosis in p53-deficient human hepatoma cell line by wild-type p53 gene transduction: Inhibition by antioxidant

Molecules and Cells

Volumn 12, Issue 1, 2001, Pages 17-24

  Lee, Kee Ho ^a   Kim, Keun Cheol ^a   Jung, Yu Jin ^a   Ham, Yong Ho ^a   Jang, Ja June ^b   Kwon, Heechung ^a   Sung, Young Cheol ^c   Kim, Sang Hoon ^d   Han, Sung Koo ^b   Kim, Chang Min ^a,e  

^a Korea Cancer Center Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d Kyung Hee University   (South Korea)

^e National Cancer Center   (South Korea)

Author keywords

Antioxidant; Apoptosis; Hepatocellular carcinoma; p21WAF1 CIP1; p53

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA FRAGMENT; GLUTATHIONE; PROTEIN P53; SCAVENGER;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; GENETIC TRANSDUCTION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NICK END LABELING; RETROVIRUS; TUMOR SUPPRESSOR GENE;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA FRAGMENTATION; FREE RADICAL SCAVENGERS; GENES, P53; GLUTATHIONE; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; RETROVIRIDAE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035980154     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Baker, S. J., Markowiz, S., Fcaron, E. R., Willson, J. K. V., and Vogelstein, B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.
2. Cai, D. W., Mukhopadhyay, T., Liu, Y., Fujiwara, T., and Roth, J. A. (1993) Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum. Gene Ther. 4, 617-624.
3. Cajot, J. F., Anderson, M. J., Lehman, T. A., Shapiro, H., Briggs, A. A., and Stanbrige, E. J. (1992) Growth suppression mediated by transduction of p53 in Hut 292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cancer Res. 52, 6956-6960.
4. Cirielli, C., Inyaku, K., Capogrossi, M. C., Yuan, X., and Williams, J. A. (1999) Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma. J. Neurooncol. 43, 99-108.
5. Clayman, G. L., Frank, D. K., Bruso, P. A., and Goepfert, H. (1999) Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin. Cancer Res. 5, 1715-1722.
6. DeAtley, S. M., Aksenov, M. Y., Aksenova, M. V., Harris, B., Hardley, R., Cole, Harper, P., Carney, J. M., and Butterfield, D. A. (1999) Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes. Cancer Lett. 136, 41-46.
7. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. (1985) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
8. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1/CIP1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
9. El-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174.
10. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B., and Roth, J. A. A. (1993) Retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53, 4129-4133.
11. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
12. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427-428.
13. Lane, D. P. (1993) A cell death in the life of p53. Nature 362, 786-787.
14. Liu, T. J., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. (1994) Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54, 3662-3667.
15. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266, 807-810.
16. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395.
17. Morgenstern, J. P. and Land, H. (1991) Choice and manipulation of retroviral vectors; in gene transfer and expression protocols, Murray, E. J. (ed.), pp. 181-206, Humana.
18. Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. (1991) Aberrations of tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 51, 5520-5525.
19. Murphy, L. D., Herzog, C. E., Rudick, J. B., Fojo, A. T., and Bates, S. E. (1990) Use of polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 13, 10351-10356.
20. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305.
21. Pritsos, C. A. and Sartorelli, A. C. (1986) Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res. 46, 3528-3532.
22. Puisieux, A., Ponchel, F., and Ozturk, M. (1993) p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells. Oncogene 8, 487-490.
23. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Isolation of total RNA from mammalian cells; in Molecular Cloning, Vol. 1, unit 7.6-7.7, Cold Spring Harbor laboratory, Cold Spring Harbor, New York.
24. Sawa, T., Wu, J., Akaike, T., and Maeda, H. (2000) Tumor-targeting chemotherapy by a xantine oxidase-polymer conjugate that generates oxygen-free radicals in tumor tissue. Cancer Res. 60, 666-671.
25. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89, 4495-4499.
26. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and El-Housein, M. E. (1994) Induction of p21 (WAF11/CIP1) during differentiation. Oncogene 9, 3389-3396.
27. 2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res. 54, 12-15.
28. Sundaresan, M., Yu, Z. X., Ferrans, V. S., Sulciner, D. J., Gutkind, J. S., Irani, K., Goldschmidt-Clermont, P. J., and Finkel, T. (1996) Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 818, 379-382.
29. Tatebe, S., Matsuura, T., Endo, K., Teramachi, K., Nakamura, T., Sato, K., and Ito, H. (1999) Adenovirus-mediated transfer of wild-type p53 gene results in apoptosis or growth arrest in human cultured gastric carcinoma cells. Int. J. Oncol. 15, 229-235.
30. Wagner, B. A., Buettner, G. R., Oberley, L. W., and Burns, C. P. (1998) Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Cancer Res. 58, 2809-2816.
31. Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., and Harris, C. C. (1995) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcriptional factor ERCC3. Proc. Natl. Acad. Sci. USA 91, 2230-2234.
32. Wills, K. N., Maneval, D. C., Menzel, P., Harris, M. P., Sutjipto, S., Vaillancourt, M., Huang, W., Johnson, D. E., Anderson, S. C., Wen, S. F., Bookstein, R., Shepard, H. M., and Gregory, R. J. (1994) Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther. 5, 1079-1088.
33. Yeo, E.-J, Hwang, Y.-C., Kang, C.-M., Choy, H. E., and Park, S. C. (2000) Reduction of UV-induced cell death in the human senescent fibroblasts. Mol. Cells 10, 415-422.
34. Yin, Y, Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948.